Evidence map›Paper›PMID 16782030›Full record

ArticleImmunity2006

HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse.

Timothy S Gomez, Sean D McCarney, Esteban Carrizosa, Christine M Labno, Erin O Comiskey, Jeffrey C Nolz, Peimin Zhu, Bruce D Freedman, Marcus R Clark, David J Rawlings and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 202 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. CD4Journal of the American Heart Association · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Timothy S GomezDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Sean D McCarneyDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Esteban CarrizosaDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Christine M LabnoDepartment of Pathology, University of Chicago, Chicago, Illinois 60637.
Erin O ComiskeyDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Jeffrey C NolzDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Peimin ZhuDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania 19104.
Bruce D FreedmanDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania 19104.
Marcus R ClarkDepartment of Medicine, University of Chicago, Chicago, Illinois 60637.
David J RawlingsDepartment of Pediatrics, Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98195.
Daniel D BilladeauDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905; Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905. Electronic address: billadeau.daniel@mayo.edu.
Janis K BurkhardtDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104. Electronic address: jburkhar@mail.med.upenn.edu.
Children's Hospital of Philadelphia · USMayo Clinic · USUniversity of Chicago · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

Novel Mechanisms of Calcium Signaling in B lymphocytesR01AI060921 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI FREEDMAN, BRUCE D · 2005 to 2014
$3.9M
Regulation of Actin Dynamics During T Cell ActivationR01AI065474 · NIAID · MAYO CLINIC ROCHESTER · PI BILLADEAU, DANIEL D · 2005 to 2014
$3.1M
REGULATION OF B CELL DEVELOPMENT AND SIGNALING BY BTKR01HD037091 · NICHD · UNIVERSITY OF WASHINGTON · PI RAWLINGS, DAVID J · 1999 to 2008
$2.7M
REGULATION OF MICROTUBLE BASED T CELL EFFECTOR FUNCTIONR01AI044835 · NIAID · UNIVERSITY OF CHICAGO · PI BURKHARDT, JANIS K. · 1999 to 2003
$1.2M
Role of HS1 in Actin Regulation During T Cell ActivationF31AI068624 · NIAID · MAYO CLINIC ROCHESTER · PI GOMEZ, TIMOTHY S · 2006 to 2006
$37k
NIAID NIH HHS F31 AI068624NIAID NIH HHS F31-AI068624NIAID NIH HHS R01 AI044835NIAID NIH HHS R01 AI060921NIAID NIH HHS R01 AI065474NIAID NIH HHS R01-AI065474NIAID NIH HHS R01-AI44835NICHD NIH HHS HD37091NICHD NIH HHS R01 HD037091
6 · The paper itself

Abstract

HS1, the leukocyte-specific homolog of cortactin, regulates F-actin in vitro and is phosphorylated in response to TCR ligation, but its role in lymphocyte activation has not been addressed. We demonstrate that HS1-deficient T cells fail to accumulate F-actin at the immune synapse (IS) and, upon TCR ligation, form actin-rich structures that are disordered and unstable. Early TCR activation events are intact in these cells, but Ca2+ influx and IL-2 gene transcription are defective. Importantly, HS1 tyrosine phosphorylation is required for its targeting to the IS and for its function in regulating actin dynamics and IL-2 promoter activity. Phosphorylation also links HS1 to multiple signaling proteins, including Lck, PLCgamma1, and Vav1, and is essential for the stable recruitment of Vav1 to the IS. Taken together, our studies show that HS1 is indispensable for signaling events leading to actin assembly and IL-2 production during T cell activation.

Indexed as

ActinsAdaptor Proteins, Signal TransducingAnimalsBlood ProteinsCalciumCells, CulturedHumansInterleukin-2Lymphocyte ActivationMiceMice, Mutant StrainsPhospholipase C gammaPhosphorylationPromoter Regions, GeneticProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellActinsAdaptor Proteins, Signal TransducingBlood ProteinsCalciumHCLS1 protein, humanInterleukin-2Phospholipase C gammaProto-Oncogene Proteins c-vavReceptors, Antigen, T-CellTyrosineVav1 protein, mouse

Identifiers

PMID16782030
PMCPMC1779661
OpenAlexW1980042862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.